DLF shares: Due to the bullish trend of global brokerage firm CLSA, there is a good shopping trend in DLF shares today. When the CLSA hoped its shares to cross ₹ 1000, investors broke down on it. This led to more than one and a half percent of the stocks. Although some investors took advantage of this boom, most of the boom was over, but the shares are still in the Green Zone. Today it has closed at ₹ 842.50 with a gain of 0.59% on BSE. It had jumped 1.66% in Intra-Day to reach DLF Share Price of ₹ 851.50.
Why is CLSA Ballish on DLF?
Brokerage firm CLSA has given DLF a high conversion outperform rating at a target price of ₹ 1025. It says that DLF is continuously performing better than its guidance. Its projects are being sold immediately, even if it has been balanced and supplied. Recently, its project Prevana North had a strong pre-sale of ₹ 11000 crore and now CLSA estimates that in this financial year 2026, the company will cross its pre-cells guidance. The brokerage firm has increased the pre-cell estimates of FY 2026-28 for DLF by 20-30%. The CLSA believes that DLF is in a more rather situation than Pierce due to four important reasons. These are the four reasons- Higher-ups Flow Generation, low cost on new land for growth, strong and increased rental portfolio and net cash balance sheet.
How is business health?
The last quarter of the last financial year 2024-25 for DLF was a bang. In January-March 2025, the company’s net profit rose from ₹ 920.7 crore to 36.3% to ₹ 6.98 crore on an annual basis. During this period, the company’s operational revenue also jumped from ₹ 2,134.8 crore to 46.5% to ₹ 3,127.6 crore. Talking at the operating level, during this time the company’s operating profit jumped 29.7% to ₹ 754.3 crore to ₹ 978.1 crore but the margin fell from ₹ 35.3% to 31.3%. Along with the result, the company also announced dividend. The company’s board approved the final dividend of ₹ 6 on every share of a face value of ₹ 2.
Now, talking about shares, on 26 September 2024 last year, its shares were at a price of ₹ 928.70, which is a one -year record high level for its shares. However, this boom of shares stopped here and in about seven months from this high level, it slipped 35.26% to the price of ₹ 601.20 on 7 April 2025, which is a record low of one year for its shares. Recovery is being done in the price from the lower level. Talking further, out of 24 analysts covering it, 22 have purchased and two have given hold ratings.
Federal Bank Shares: Shares on record high, investors tweeting on this plan of bank
Pharma sector’s second largest deal, Torrent Pharma will buy JB Pharma in so long
Disclaimer: Advice or idea experts/brokerage firms on Moneycontrol.com have their own personal views. The website or management is not responsible for this. Moneycontrol advises to users that always seek the advice of certified experts before taking any investment decision.